Literature DB >> 16096159

Investigation, treatment and monitoring of late-onset hypogonadism in males.

E Nieschlag1, R Swerdloff, H M Behre, L J Gooren, J M Kaufman, J-J Legros, B Lunenfeld, J E Morley, C Schulman, C Wang, W Weidner, F C W Wu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16096159     DOI： 10.1080/13685530500130969

Source DB:  PubMed          Journal:  Aging Male        ISSN： 1368-5538            Impact factor:   5.892


× No keyword cloud information.
  11 in total

Review 1.  The treatment of late-onset hypogonadism.

Authors:  Oktay Üçer; Bilal Gümüş
Journal:  Turk J Urol       Date:  2014-03-24

2.  [LOH (late-onset hypogonadism) or the "aging male"].

Authors:  H Sperling; F Jockenhövel; W Stackl; F-M Köhn; G Ludwig
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

Review 3.  Testosterone replacement therapy for late-onset hypogonadism: current trends in Korea.

Authors:  Young Hwii Ko; Je Jong Kim
Journal:  Asian J Androl       Date:  2011-05-16       Impact factor: 3.285

4.  Cachexia and aging: an update based on the Fourth International Cachexia Meeting.

Authors:  J E Morley; S D Anker; W J Evans
Journal:  J Nutr Health Aging       Date:  2009-01       Impact factor: 4.075

Review 5.  Insights into the Regulation on Proliferation and Differentiation of Stem Leydig Cells.

Authors:  Zhuo-Jie Liu; Yong-Hui Liu; Sheng-Yu Huang; Zhi-Jun Zang
Journal:  Stem Cell Rev Rep       Date:  2021-02-17       Impact factor: 5.739

6.  Testosterone replacement alone for testosterone deficiency syndrome improves moderate lower urinary tract symptoms: one year follow-up.

Authors:  Young Hwii Ko; Du Geon Moon; Ki Hak Moon
Journal:  World J Mens Health       Date:  2013-04-23       Impact factor: 5.400

7.  The effect of anthocyanin on the prostate in an andropause animal model: rapid prostatic cell death by apoptosis is partially prevented by anthocyanin supplementation.

Authors:  Hoon Jang; Woong Jin Bae; Su Jin Kim; Seoung Mo Yuk; Dong Seok Han; U Syn Ha; Sung Yeoun Hwang; Shin Hee Yoon; Zhiping Wang; Sae Woong Kim
Journal:  World J Mens Health       Date:  2013-12-24       Impact factor: 5.400

8.  Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men.

Authors:  Bruno Lunenfeld; George Mskhalaya; Michael Zitzmann; Stefan Arver; Svetlana Kalinchenko; Yuliya Tishova; Abraham Morgentaler
Journal:  Aging Male       Date:  2015-02-06       Impact factor: 5.892

9.  The benefits and risks of testosterone replacement therapy: a review.

Authors:  Nazem Bassil; Saad Alkaade; John E Morley
Journal:  Ther Clin Risk Manag       Date:  2009-06-22       Impact factor: 2.423

10.  Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations.

Authors:  C Wang; E Nieschlag; R Swerdloff; H M Behre; W J Hellstrom; L J Gooren; J M Kaufman; J-J Legros; B Lunenfeld; A Morales; J E Morley; C Schulman; I M Thompson; W Weidner; F C W Wu
Journal:  Eur J Endocrinol       Date:  2008-11       Impact factor: 6.664
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.